Emcure Pharmaceuticals confirms that securities received for dematerialization during the quarter ended September 30, 2025, have been processed and confirmed with the depositories. The company has also confirmed that the security certificates received for dematerialization have been mutilated and cancelled after verification. The registrar has been updated according to regulatory requirements, ensuring compliance and accurate record-keeping.
Security Dematerialization Confirmation
Emcure Pharmaceuticals has confirmed the processing of security certificates received for dematerialization during the quarter ending September 30, 2025. This confirmation follows the necessary regulatory guidelines and involves coordination with depository participants.
Certificate Processing Details
The company confirms that all received security certificates have been processed, with accepted or rejected statuses communicated to the respective depositories. Furthermore, the original security certificates received during the dematerialization process have been duly mutilated and cancelled. Verification by the depository participant has been completed.
Regulatory Compliance
The register of members has been updated to reflect the changes in ownership resulting from the dematerialization process. The appropriate substitutions have been made within the prescribed timelines, ensuring ongoing compliance. This process ensures transparent record-keeping for all security holders.
Source: BSE
